CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,817,138 | $30,582,000 | 2.98% |
| SENZAR ASSET MANAGEMENT, LLC | 29,821 | $502,000 | 1.45% |
| INGALLS & SNYDER LLC | 1,337,862 | $22,516,000 | 1.04% |
| Matarin Capital Management, LLC | 316,858 | $5,332,720,000 | 0.39% |
| KNOTT DAVID M | 51,557 | $868,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $279,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 123,700 | $2,082,000 | 0.10% |
| Spark Investment Management LLC | 97,200 | $1,635,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 941,282 | $15,841,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 67,220 | $1,131,000 | 0.06% |